Mason Jacobs
About Mason Jacobs
Mason Jacobs is the Executive Territory Business Manager Immunology at Bristol Myers Squibb, with extensive experience in the healthcare industry and a background in marketing and finance from the University of Utah.
Current Role at Bristol Myers Squibb
Mason Jacobs holds the position of Executive Territory Business Manager Immunology at Bristol Myers Squibb. Based in Utah and Las Vegas, he is responsible for managing the immunology business and ensuring the successful implementation of strategies to promote key pharmaceutical products. His role involves fostering relationships with healthcare professionals and institutions, ensuring the efficient launch and support of immunology treatments.
Previous Positions at Takeda
Before joining Bristol Myers Squibb, Mason Jacobs served in various capacities at Takeda. Between 2014 and 2020, he worked as a Senior Clinical Sales Specialist focusing on Inflammatory Bowel Disease, Immunology, and Inflammation across Utah, Las Vegas, and Idaho. Prior to this role, he was a Territory Manager for 11 years, handling responsibilities in Utah. His tenure at Takeda equipped him with in-depth knowledge and expertise in clinical sales and territory management.
Work Experience at Madison Square Garden Entertainment Corp.
From 1999 to 2003, Mason Jacobs worked with MSG Networks and The New York Knicks at Madison Square Garden Entertainment Corp. Based in New York City, he gained substantial experience in the entertainment and sports marketing field. This role helped him develop a diverse skill set and broadened his professional network.
Educational Background
Mason Jacobs attended the University of Utah - David Eccles School of Business, where he studied Communication with a focus on Marketing and Finance, earning a Bachelor of Business Administration between 1997 and 2000. He also completed a course in Religion at The Church of Jesus Christ of Latter-Day Saints from 1994 to 1996. His education has provided him with a robust foundation in business administration and strategic communication.
Product Launch Success
Mason Jacobs successfully launched ZEPOSIA (ozanimod) for the treatment of Multiple Sclerosis and Ulcerative Colitis. This achievement highlights his expertise and effectiveness in overseeing product introductions in the pharmaceutical sector. His ability to lead successful launches underscores his impactful role within the organization.